Ginkgo Datapoints and Berlin-based Apheris today announced that the Antibody Developability Consortium has kicked off with its founding members. The Consortium is a new industry collaboration designed…
This is a summary
The full article is published by Tech.eu. We hold only a headline and a short summary here.
Read the full article